- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05460104
Impact of the Use of VERT on Body Image After Bariatric Surgery (BARIAREV)
Impact of the Use of Virtual Reality Exposure Therapy on Body Image After Bariatric Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Libourne, France, 33500
- CH de Libourne - Hôpital Robert BOULIN
-
Pessac, France, 33604
- Chu de Bordeaux - Hopital Haut-Leveque
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
- inclusion criteria: patients who underwent bariatric surgery in the weight stabilization phase (between 18 and 30 months after surgery) presenting dissatisfaction with their body image according to the BSQ (score ≥ 111), to be affiliated to the French social security system. The prior, free and informed consent of the patient shall be obtained.
- exclusion criteria: patients with disabling nausea (Motion Sickness) from previous use of a virtual reality headset, patients who had from post-bariatric reconstructive surgery, epileptic patients, decompensation of a psychiatric pathology
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Expérimental
Virtual Reality Exposure Therapy will be realised.
|
Virtual reality sessions with a psychologist (30 minutes per session) once a week for 10 weeks.
Work of the psychologist on a virtual environment created for the protocol in partnership with the company.
|
|
Active Comparator: Control
Standard care without VRET
|
Standard care is medical follow-up, no specific psychological care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Shape Questionnaire
Time Frame: Between inclusion and 12 months after.
|
Average variation of the Body Shape Questionnaire (BSQ). BSQ is a 34 questions questionnaire, for each question the answer is 1 to 6, 1 for "never" and 6 for "always". (score ≥ 111, moderate body image concern) |
Between inclusion and 12 months after.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change weight
Time Frame: Between inclusion day and Month 3
|
Average weight loss in %, in the two arms.
|
Between inclusion day and Month 3
|
|
Change weight
Time Frame: Between Month 6 and Month 12
|
Average weight loss in %, in the two arms.
|
Between Month 6 and Month 12
|
|
Body Image Assessment for Obesity questionnaire
Time Frame: Between inclusion day and Month 3
|
Average variation in Body Image Assessment for Obesity, in each arm.
The patient surrounds the figure that seems to closest to his or her current figure.
And then he surrounds the figure he would like to achieve.This is a schematic representation of the body, from the thinnest silhouette in 1 to the widest in 18
|
Between inclusion day and Month 3
|
|
Body Image Assessment for Obesity questionnaire
Time Frame: Between Month 6 and Month 12
|
Average variation in Body Image Assessment for Obesity questionnaire, in each arm.The patient surrounds the figure that seems to closest to his or her current figure.
And then he surrounds the figure he would like to achieve.
This is a schematic representation of the body, from the thinnest silhouette in 1 to the widest in 18
|
Between Month 6 and Month 12
|
|
Quality of Life, Obesity and Dietetics questionnaire assess quality of life
Time Frame: Between inclusion day and Month 3
|
Average variation of the Quality of Life, Obesity and Dietetics, in each arm.
This questionnaire consists of 36 questions that focus on the effects of the weight problem as experienced by the patient.
For each question the patient can answer from 1 to 5: 1 always, 5 never.
|
Between inclusion day and Month 3
|
|
Quality of Life, Obesity and Dietetics questionnaire assess quality of life
Time Frame: Between Month 6 and Month 12
|
Average variation of the Quality of Life, Obesity and Dietetics, in each arm.
This questionnaire consists of 36 questions that focus on the effects of the weight problem as experienced by the patient.
For each question the patient can answer from 1 to 5: 1 always, 5 never.
|
Between Month 6 and Month 12
|
|
Self-esteem
Time Frame: Between inclusion day and Month 3
|
Average variation of the Rosenberg Self-Esteem Scale, in each arm. The scale represents an assessment of the person's overall self-esteem. The scale consists of 10 statements measured on a scale of 1 to 4: 1 "Totally disagree", 4 "Totally agree". The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. |
Between inclusion day and Month 3
|
|
Self-esteem
Time Frame: Between Month 6 and Month 12
|
Average variation of the Rosenberg Self-Esteem Scale, in each arm.The scale represents an assessment of the person's overall self-esteem. The scale consists of 10 statements measured on a scale of 1 to 4: 1 "Totally disagree", 4 "Totally agree". The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. |
Between Month 6 and Month 12
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2021/37
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Experimental
-
Polish Mother Memorial Hospital Research InstituteCompletedBottle Feeding | PrematurePoland
-
Finis Terrae UniversityNot yet recruitingPostoperative Pain | Respiratory ComplicationChile
-
University of Illinois at ChicagoRecruiting
-
Riphah International UniversityRecruitingAthletic Performance | Muscle StrengthPakistan
-
Suleyman Demirel UniversityRecruitingOsteoporosis (Senile)Turkey (Türkiye)
-
University of AlcalaRecruitingTo be Approved by the Ethics CommitteeSpain
-
European University Miguel de CervantesHospital Clínico Universitario de ValladolidNot yet recruiting
-
Amasya UniversityCompleted
-
Le Mans UniversiteActive, not recruiting
-
Center for Health Sciences, SerbiaNot yet recruitingCognitive Deficits, Mild